Notice of Intent to Grant Exclusive Patent License; NanoDynamics, Inc., 29321 [E6-7730]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 98 / Monday, May 22, 2006 / Notices
U.S.C. App. 2). The Executive Session of
the meeting will consist of discussions
of personnel issues at the Naval
Academy and internal Board of Visitors
matters. Discussion of such information
cannot be adequately segregated from
other topics, which precludes opening
the executive session of this meeting to
the public. Accordingly, the Secretary of
the Navy has determined in writing that
the meeting shall be partially closed to
the public because it will be concerned
with matters listed in section 552b(c)(2),
(5), (6), (7), and (9) of title 5, United
States Code.
Dated: May 11, 2006.
Saundra K. Melancon,
Paralegal Specialist, Alternate Federal
Register Liaison Officer.
[FR Doc. E6–7729 Filed 5–19–06; 8:45 am]
evidence, if any, not later than June 6,
2006.
ADDRESSES: Written objections are to be
filed with the Naval Research
Laboratory, Code 1004, 4555 Overlook
Avenue, SW., Washington, DC 20375–
5320.
FOR FURTHER INFORMATION CONTACT:
Head, Technology Transfer Office, NRL
Code 1004, 4555 Overlook Avenue, SW.,
Washington, DC 20375–5320, telephone
202–767–7230. Due to U.S. Postal
delays, please FAX 202–404–7920, email techtran@utopia.nrl.navy.mil, or
use courier delivery to expedite
response.
(Authority: 35 U.S.C. 207, 37 CFR part 404)
Dated: May 16, 2006.
Saundra K. Melancon,
Paralegal Specialist, Office of the Judge
Advocate General, Alternate Federal Register
Liaison Officer.
[FR Doc. E6–7730 Filed 5–19–06; 8:45 am]
BILLING CODE 3810–FF–P
DEPARTMENT OF DEFENSE
BILLING CODE 3810–FF–P
Department of the Navy
Notice of Intent to Grant Exclusive
Patent License; NanoDynamics, Inc.
DEPARTMENT OF EDUCATION
RIN 1865–ZA03
Department of the Navy, DoD.
ACTION: Notice.
cchase on PROD1PC60 with NOTICES
AGENCY:
SUMMARY: The Department of the Navy
hereby gives notice of its intent to grant
to NanoDynamics, Inc., a revocable,
nonassignable, exclusive license to
practice in the field of Halloysite
microtubules for the elution of biocidal,
antifungal, or other antimicrobial agents
for the prevention of growth of bacteria
and/or mold in Building Materials in
the residential, commercial,
institutional, and healthcare
construction products market excluding
paint, stain, varnish and other finish
coatings associated with structures in
the United States and certain foreign
countries, the Government-owned
inventions described in U.S. Patent No.
5,492,696: Controlled Release
Microstructures, Navy Case No.
76,896.//U.S. Patent No. 5,651,976:
Controlled Release of Active Agents
Using Inorganic Tubules, Navy Case No.
76,652.//U.S. Patent No. 5,705,191:
Sustained Delivery of Active
Compounds from Tubules, with
Rational Control, Navy Case No.
77,037.//U.S. Patent No. 6,280,759:
Method of Controlled Release and
Controlled Release Microstructures,
Navy Case No. 78,215 and any
continuations, divisionals or re-issues
thereof.
Anyone wishing to object to the
grant of this license must file written
objections along with supporting
DATES:
VerDate Aug<31>2005
20:16 May 19, 2006
Jkt 208001
Grants for School-Based Student
Drug-Testing Programs
Office of Safe and Drug-Free
Schools, Department of Education.
ACTION: Notice of proposed priority,
eligibility and application requirements,
and selection criteria.
AGENCY:
SUMMARY: The Assistant Deputy
Secretary for Safe and Drug-Free
Schools proposes a priority, eligibility
and application requirements, and
selection criteria under the Safe and
Drug-Free Schools and Communities
National Programs for the School-Based
Student Drug-Testing Programs grant
program. The Assistant Deputy
Secretary may use the priority,
requirements, and selection criteria for
competitions in fiscal year 2006 and
later years. We take this action to focus
Federal financial assistance on an
identified national need. We intend for
the priority, requirements, and selection
criteria to contribute substantially to
existing knowledge about the efficacy of
mandatory random student drug testing
as a means of deterring student drug
use.
DATES: We must receive your comments
on or before June 21, 2006.
ADDRESSES: Address all comments about
the priority, requirements, and selection
criteria to Robyn L. Disselkoen, U.S.
Department of Education, 400 Maryland
Avenue, SW., room 3E251, Washington,
DC 20202–6450. If you prefer to send
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
29321
your comments through the Internet,
use the following address:
OSDFSdrugtesting@ed.gov.
You must include the term
‘‘Comments on 2006 Student DrugTesting Notice’’ in the subject line of
your electronic message.
FOR FURTHER INFORMATION CONTACT:
Robyn Disselkoen at (202) 260–3954.
If you use a telecommunications
device for the deaf (TDD), you may call
the Federal Relay Service (FRS) at 1–
800–877–8339.
Individuals with disabilities may
obtain this document in an alternative
format (e.g., Braille, large print,
audiotape, or computer diskette) on
request to the contact person listed
under FOR FURTHER INFORMATION
CONTACT.
SUPPLEMENTARY INFORMATION:
Invitation to Comment
We invite you to submit comments
regarding the proposed priority,
requirements, and selection criteria. To
ensure that your comments have
maximum effect in developing the
notice of final priority, eligibility and
application requirements, and selection
criteria, we urge you to identify clearly
the specific priority, requirement, or
selection criterion that each comment
addresses.
We invite you to assist us in
complying with the specific
requirements of Executive Order 12866
and its overall requirement of reducing
regulatory burden that might result from
the proposed priority, requirements, and
selection criteria. Please let us know of
any further opportunities we should
take to reduce potential costs or increase
potential benefits while preserving the
effective and efficient administration of
the program.
During and after the comment period,
you may inspect all public comments
about the proposed priority,
requirements, and selection criteria in
room 3E251, 400 Maryland Avenue,
SW., Washington DC, between the hours
of 8:30 a.m. and 4 p.m., Washington, DC
time, Monday through Friday of each
week except Federal holidays.
Assistance to Individuals With
Disabilities in Reviewing the
Rulemaking Record
On request, we will supply an
appropriate aid, such as a reader or
print magnifier, to an individual with a
disability who needs assistance to
review the comments or other
documents in the public rulemaking
record for the proposed priority,
requirements, and selection criteria. If
you want to schedule an appointment
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 71, Number 98 (Monday, May 22, 2006)]
[Notices]
[Page 29321]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7730]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent to Grant Exclusive Patent License; NanoDynamics,
Inc.
AGENCY: Department of the Navy, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to NanoDynamics, Inc., a revocable, nonassignable, exclusive
license to practice in the field of Halloysite microtubules for the
elution of biocidal, antifungal, or other antimicrobial agents for the
prevention of growth of bacteria and/or mold in Building Materials in
the residential, commercial, institutional, and healthcare construction
products market excluding paint, stain, varnish and other finish
coatings associated with structures in the United States and certain
foreign countries, the Government-owned inventions described in U.S.
Patent No. 5,492,696: Controlled Release Microstructures, Navy Case No.
76,896.//U.S. Patent No. 5,651,976: Controlled Release of Active Agents
Using Inorganic Tubules, Navy Case No. 76,652.//U.S. Patent No.
5,705,191: Sustained Delivery of Active Compounds from Tubules, with
Rational Control, Navy Case No. 77,037.//U.S. Patent No. 6,280,759:
Method of Controlled Release and Controlled Release Microstructures,
Navy Case No. 78,215 and any continuations, divisionals or re-issues
thereof.
DATES: Anyone wishing to object to the grant of this license must file
written objections along with supporting evidence, if any, not later
than June 6, 2006.
ADDRESSES: Written objections are to be filed with the Naval Research
Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320.
FOR FURTHER INFORMATION CONTACT: Head, Technology Transfer Office, NRL
Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-5320,
telephone 202-767-7230. Due to U.S. Postal delays, please FAX 202-404-
7920, e-mail techtran@utopia.nrl.navy.mil, or use courier delivery to
expedite response.
(Authority: 35 U.S.C. 207, 37 CFR part 404)
Dated: May 16, 2006.
Saundra K. Melancon,
Paralegal Specialist, Office of the Judge Advocate General, Alternate
Federal Register Liaison Officer.
[FR Doc. E6-7730 Filed 5-19-06; 8:45 am]
BILLING CODE 3810-FF-P
